Skip to main content

Advertisement

SpringerLink
Log in

High-mobility group box 1 protein in endophthalmitis

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

High-mobility group box 1 protein (HMGB1) is recently described as a late mediator of lethal endotoxemia with proinflammatory cytokine-like properties. The purpose of this study was to determine whether HMGB1 is involved in endophthalmitis.

Methods

In this retrospective case-control study, vitreous levels of HMGB1 were measured by an enzyme-linked immunosorbent assay in ten eyes with endophthalmitis, and in 12 eyes with idiopathic macular holes which served as controls. Formalin-fixed and paraffin-embedded tissue sections of an enucleated eye with endophthalmitis, and a control eye with recurrent conjunctival malignant melanoma, were analyzed by immunohistochemistry with an anti-HMGB1 antibody.

Results

The vitreous HMGB1 level of the patients with endophthalmitis was 13.96 ± 17.17 ng/ml (mean±SD), which was significantly higher than that of the controls (0.236 ± 0.128 ng/ml; P = .0006, Mann-Whitney U test). There were significant correlations between HMGB1 level and disease duration, presenting visual acuity, and final visual acuity. In the eye with endophthalmitis, HMGB1 expression was diffusely observed, particularly in the extranuclear region of the retina and the choroid with infiltrating inflammatory cells.

Conclusion

HMGB1 can be released in the vitreous of eyes with endophthalmitis depending on inflammation and tissue damage. Our results suggest that HMGB1 may be a late mediator of endophthalmitis, and related to the progression of endophthalmitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–195

    Article  PubMed  CAS  Google Scholar 

  2. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331–342

    Article  PubMed  CAS  Google Scholar 

  3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251

    Article  PubMed  CAS  Google Scholar 

  4. Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, Maruyama I (2007) High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 5:109–116

    Article  PubMed  CAS  Google Scholar 

  5. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y, Uemoto S, Yamada S, Maruyama I (2005) Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 94:975–979

    PubMed  CAS  Google Scholar 

  6. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971–981

    Article  PubMed  CAS  Google Scholar 

  7. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101:296–301

    Article  PubMed  CAS  Google Scholar 

  8. Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR (2006) Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 82:807–815

    Article  PubMed  CAS  Google Scholar 

  9. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I (2003) High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 49:1535–1537

    Article  PubMed  CAS  Google Scholar 

  10. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE (2007) High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33:1347–1353

    Article  PubMed  CAS  Google Scholar 

  11. Hoppe G, Rayborn ME, Sears JE (2007) Diurnal rhythm of the chromatin protein Hmgb1 in rat photoreceptors is under circadian regulation. J Comp Neurol 501:219–230

    Article  PubMed  CAS  Google Scholar 

  12. Lemley CA, Han DP (2007) Endophthalmitis: a review of current evaluation and management. Retina 27:662–680

    Article  PubMed  Google Scholar 

  13. Russell JA (2006) Management of sepsis. N Engl J Med 355:1699–1713

    Article  PubMed  CAS  Google Scholar 

  14. Pathengay A, Shah GY, Das T, Sharma S (2006) Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. Am J Ophthalmol 141:938–940

    Article  PubMed  CAS  Google Scholar 

  15. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ (1999) Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol 83:1050–1055

    Article  PubMed  CAS  Google Scholar 

  16. Jiang W, Pisetsky DS (2007) Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. Nat Clin Pract Rheumatol 3:52–58

    Article  PubMed  CAS  Google Scholar 

  17. Petropoulos IK, Vantzou CV, Lamari FN, Karamanos NK, Anastassiou ED, Pharmakakis NM (2006) Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefes Arch Clin Exp Ophthalmol 244:1322–1328

    Article  PubMed  CAS  Google Scholar 

  18. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. Faseb J 21:3904–3916

    Article  PubMed  CAS  Google Scholar 

  19. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26:6413–6421

    Article  PubMed  CAS  Google Scholar 

  20. Pedrazzi M, Raiteri L, Bonanno G, Patrone M, Ledda S, Passalacqua M, Milanese M, Melloni E, Raiteri M, Pontremoli S, Sparatore B (2006) Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem 99:827–838

    Article  PubMed  CAS  Google Scholar 

  21. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517–524

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare of the Japanese Government (to I.M.).

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, 8–35–1, Sakuragaoka, Kagoshima, 890–8520, Japan

    Noboru Arimura, Yuya Ki-i & Taiji Sakamoto

  2. Department of Laboratory and Vascular Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8–35–1, Sakuragaoka, Kagoshima, 890–8520, Japan

    Teruto Hashiguchi & Ikuro Maruyama

Authors
  1. Noboru Arimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuya Ki-i
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teruto Hashiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Taiji Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ikuro Maruyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taiji Sakamoto.

Additional information

The authors have no financial or proprietary interests in this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arimura, N., Ki-i, Y., Hashiguchi, T. et al. High-mobility group box 1 protein in endophthalmitis. Graefes Arch Clin Exp Ophthalmol 246, 1053–1058 (2008). https://doi.org/10.1007/s00417-008-0827-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-008-0827-2

Keywords

Search

Navigation